| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | — | -51.6% |
| Cost of Revenue | $1.9M | — | -46.6% |
| Gross Profit | -$234K | — | -102.8% |
| R&D Expense | $99K | — | -9.0% |
| SG&A Expense | $2.2M | — | -16.1% |
| Operating Income | -$2.9M | — | +9.6% |
| Pre-tax Income | -$2.7M | — | +15.4% |
| Net Income | -$2.7M | — | +15.4% |
| EPS (Basic) | -$6.68 | — | -261.1% |
| EPS (Diluted) | -$6.68 | — | -261.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.5M | +641.8% | +10.2% |
| Accounts Receivable | $319K | +227.2% | -20.1% |
| Current Assets | $14.0M | +548.0% | +8.1% |
| Total Assets | $39.4M | +53.4% | +113.5% |
| Current Liabilities | $3.4M | -7.5% | -23.3% |
| Stockholders' Equity | $36.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | -39.4% |
| Investing Cash Flow | -$1.9M | — | -61.4% |
| Financing Cash Flow | $16.6M | — | +70.8% |
| +164.1% |